May is Brain Tumor Awareness Month.
@AstraZeneca and @AlexionPharmaUS , we are committed to advancing rare oncology research—including brain tumors—where innovation can make the greatest impact on patients and families.
#BrainTumorAwareness #RareDisease #Oncology #Innovation

Online Now: Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunity dlvr.it/TSKVFp

We're fueling your Friday with positivity and motivation

Online Now: A photoreceptor state links aggressive brain tumors in children dlvr.it/TRbCvd

CAR T cells are laboratory-engineered immune cells that provide effective treatment for some cancers. Progress is being made towards creating these cells in vivo

go.nature.com/3NtYGY4

#Thanksgiving is not only to be greatful for all the "good" in our life, but also reflect on the “bad" and recommit our energies to giving thanks and just "#giving". Happy and blessed thanksgiving to everyone who celebrates it

Brain metastasis: From etiology to ecotypes dlvr.it/TLxJTF

The role of ultra-processed food (UPF) in obesity | ⁦@NatureRevEndo⁩ —time to sound the alarm 🚨 on UPF! Nice review that focus on the biological link between UPF and Obesity nature.com/articles/s4157…

Pan-cancer human brain metastases atlas at single-cell resolution dlvr.it/TLw4ZN

In the latest issue! Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis dlvr.it/TLv0mQ

Recent research found that #temozolomide rechallenge is a common, safe, and effective second-line option for patients with MGMT-methylated, #IDHwildtype #GBM following first-line lomustine/temozolomide therapy.

Read the full article in our latest issue: bit.ly/4497BUq

Policy Corner by Abdullah H. Ishaque, MD, PhD (@ahishaque), @AbdiAidid, JD, LLM, and @gelarehzadeh, MD, PhD: Lessons from the Failure of Canada’s Artificial Intelligence and Data Act nejm.ai/4ekfI3Q

#AIinMedicine

Super excited to share our newest piece out today @NatureRevCancer linking age-induced metabolic reprogramming to cancer development. nature.com/articles/s4156…

🟡 July is #sarcomaawarenessmonth 🟡
Sarcoma is a rare and often overlooked cancer, but its impact is deeply felt by every patient and family it touches. @AstraZeneca and @AlexionPharmaUS, we are committed to transforming outcomes for patients with rare cancers like #sarcoma

The more potent and bespoke immunotherapy vs cancer, the better. Today's example is a neoantigen vaccine vs melanoma
cell.com/cell/fulltext/…

Online Now: KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer dlvr.it/TLrhCk

I'm happy to share that I’ve started a new position as Executive Director, Head of Rare Cancer Discovery @AstraZeneca and @AlexionPharmaUS

Looking forward to what’s ahead!

Excited to lead efforts across discovery and clinical strategy to bring therapies for patients with rare cancers where the need is great and the impact can be life-changing. It’s an honor to join a team so dedicated to advancing science and making a real difference for patients

Online now: Niche-specific therapeutic targeting of myeloid cells in the central nervous system dlvr.it/TKYNlp

Good update of recommendation for LGG management in the era of vorssidenib. More trials in progress
@EANOassociation
@EORTC
@SapienzaRoma
@ESTRO_RT
@myESMO